| Particulars |
| Company Name |
ERIS Lifesciences Ltd |
Year End |
202503 |
| Full Year |
| Equity (Rs Cr.) |
13.62 |
B.V. Rs |
203.40 |
| Sales Rs Cr. |
1,704.03 |
NP Rs Cr. |
76.04 |
| NP Var% |
-74.00 |
Div% |
735.00 |
| CPS Rs |
18.90 |
EPS Rs |
5.60 |
| Traded Value(Rs Lakhs) |
1,808.90 |
52 Week High |
1,910.00 |
| 52 Week Low |
1,130.00 |
Price BSE |
1,664.00 |
| Price NSE |
1,666.00 |
Market Capital(Rs Cr.) |
22,667.85 |
| P/C Ratio |
87.90 |
P/E Ratio |
298.10 |
| Price Vs.BV |
8.18 |
|
| Latest Quarter |
| Year End |
202509 |
Sales Rs Cr. |
637.58 |
| NP Rs Cr. |
149.57 |
NP Var % |
432.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
1,526.13 |
| OPM |
27.51 |
NP |
116.31 |
| NP Var% |
142.31 |
EPS |
20.69 |
| PE |
80.43 |
|
|